Ravi Shekar Ananthula

Dr. Ravi S. Ananthula is the Chief Scientific Officer at PharmaDEM Solutions, with a distinguished 19-year career in drug discovery, clinical trials, and product development. His significant achievements include contributing to 8 New Drug Applications (NDAs) and over 20 Abbreviated New Drug Applications (ANDAs). Dr. Ananthula has been a driving force in India's digital transformation in pharmaceuticals through his software innovations, SoluDEM and FormDEM. He has played a crucial role in COVID-19 drug repurposing, developed the first nasal peptide delivery system globally, and advanced peptide synthesis projects. His career includes work with prominent companies such as Eli Lilly and Company, Dr. Reddy's Laboratories, and Aragen, across both the USA and India. Dr. Ananthula is also an active member of the international computational chemistry consortium and holds multiple patents and publications.

Doctor of Philosophy (Ph.D.), Medicinal and Pharmaceutical Chemistry

Osmania University

Master of Business Administration (MBA), Project Management

Institute of Management Technology, Hyderabad (2014 - 2016)

PG Diploma in Intellectual Property Management

Osmania University (2010 - 2011)

Master's degree, Life sciences

Acharya Nagarjuna University (2003)

CSO & Executive Director, PharmaDEM Solutions